Skip to content

Pilot study on the possible effectiveness of a three-day treatment program (The Challenge) in persons with chronic pain

Pilot study on the possible effectiveness of a three-day treatment program (The Challenge) in persons with chronic pain - The Challenge Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41138
Enrollment
40
Registered
2014-07-16
Start date
2014-07-30
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronische pijn chronic pain chronic pain syndromes

Interventions

The components of The Challenge study are 1) large group sessions, 2) small group sessions, 3) consultations (carrousel), 4) a theatre evening, and 5) start of the day with a joint activity (optiona

Sponsors

DC Klinieken Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: For persons with chronic pain the inclusion criteria are: 1) Diagnosis of chronic pain, 2) Diagnosis at least for 6 months, 3) Willing and able to participate in the study, 4) Written informed consent. For partners or informal caregivers the inclusion criteria are: 1) Willing and able to participate in the study, 4) Written informed consent.

Exclusion criteria

Exclusion criteria: For persons with chronic pain the exclusion criteria are: 1) No diagnosis of chronic pain, 2) Diagnosis less than 6 months, 3) Not willing or unable to participate in the study, 4) No written informed consent. For partners or informal caregivers the exclusion criteria are: 1) Not willing or unable to participate in the study, 4) No written informed consent.

Design outcomes

Primary

MeasureTime frame
EQ-5D-5L Quality of Life scores, IPA-32 Impact on Participation and Autonomy scores.

Secondary

MeasureTime frame
VAS Global pain score, SOPA Survey of Pain Attitudes scores, 4DKL Distress, Anxiety, Depression and Somatisation scores.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)